GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Indrayani Biotech Ltd

Indrayani Biotech Ltd: Newspaper Publication for Rights Issue Matters

FUNDRAISE ◆ Monitor Closely LOW RISK
📅 Filed on BSE: 10 Nov 2026, 03:48 PM IST  ·  BSE ID: 425b27b4-b76a-44bf-aa24-8217659d7e21
View Original BSE Filing (PDF)
💡
In Simple Terms
The company has officially published news in newspapers about its rights issue process.
🤖 AI Summary
  • Indrayani Biotech Ltd publishes newspaper notices for rights issue matters.
  • Recent rights issue saw allotment of 83,64,036 shares.
  • Company's paid-up capital now stands at Rs. 53,25,47,648.
  • BSE had previously granted listing approval for the proposed rights issue.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Paid-up Capital
53,25,47,648
Rights Shares Allotted
83,64,036
🏢 How This Affects the Company
💰
Financial Impact
The completion of the rights issue and allotment of shares has increased the company's paid-up capital to Rs. 53,25,47,648.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this intimation.
👤
Who Is Affected
Shareholders who participated in the rights issue are directly affected by the allotment and capital increase.
🔍
Management Signal
This indicates continued execution of the company's capital raising strategy through rights issues.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Confirmation of finalization of rights issue terms.
Updates on utilization of funds raised from the rights issue.
Future financial results post-capital infusion.
LOW RISK This filing is a procedural update regarding a completed rights issue process.
💡 Investor Takeaway
Indrayani Biotech Ltd has published newspaper notices concerning its rights issue. The company's paid-up capital has increased to Rs. 53,25,47,648 following the allotment of 83,64,036 rights shares.
⚖️ Strengths & Concerns

✅ Positives

  • Increased paid-up capital to Rs. 53,25,47,648 following rights issue allotment.
📅 Company Track Record
Indrayani Biotech Ltd previously postponed its Rs. 49.90 crore partly paid rights issue in June 2026.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What is Indrayani Biotech Ltd announcing with the newspaper publication?
Indrayani Biotech Ltd is publishing newspaper notices related to matters concerning its rights issue.
What is Indrayani Biotech Ltd's current paid-up capital?
The company's paid-up capital has reached Rs. 53,25,47,648 following the allotment of rights shares.
How many rights shares were allotted by Indrayani Biotech Ltd?
A total of 83,64,036 rights shares were allotted by Indrayani Biotech Ltd.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.